SCHEMBL10112707

SCHEMBL10112707

c1ccc(-c2ccc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccc(-c7ccccc7)cc6)c5c43)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.57
KDM4E B2RXH2 1/20 0.57
ATM Q13315 1/20 0.57
HDAC4 P56524 1/20 0.44
KMT2A Q03164 3/20 0.42
IL1R1 P14778 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 1/20 0.41
PTPN1 P18031 2/20 0.39
CYP19A1 P11511 1/20 0.38
MAPK8 P45983 2/20 0.38
MAPK9 P45984 1/20 0.38
FAAH O00519 1/20 0.37
MGLL Q99685 1/20 0.37
AVPR1A P37288 1/20 0.37
HSP90AA1 P07900 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22003585 1.00 L3MBTL1 (0.57) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12691156 0.98 L3MBTL1 (0.61) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL19863523 0.98 L3MBTL1 (0.61) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17245347 0.98 L3MBTL1 (0.61) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL18593810 0.98 L3MBTL1 (0.61) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL27426970 0.96 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL10205968 0.96 L3MBTL1 (0.63) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15073810 0.94 L3MBTL1 (0.61) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12690890 0.94 L3MBTL1 (0.67) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL23008255 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030894-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2024-07-09 US disclosed
US-12030894-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2024-07-09 US disclosed
WO-2024128540-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER 엘티소재주식회사 2024-06-20 WO disclosed
WO-2024111958-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE AND ORGANIC OPTOELECTRONIC DIODE AND DISPLAY DEVICE 삼성에스디아이 주식회사 2024-05-30 WO disclosed
WO-2024049156-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE 삼성에스디아이 주식회사 2024-03-07 WO disclosed
EP-4328285-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2024-02-28 EP disclosed
US-20240032417-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2024-01-25 US disclosed
US-20240032417-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2024-01-25 US disclosed
US-20240023434-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2024-01-18 US disclosed
US-11844271-B2 Organic compound, composition, organic optoelectronic device, and display apparatus SAMSUNG SDI CO., LTD. (KR) 2023-12-12 US disclosed
US-20150228909-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-08-13 US disclosed
WO-2015108301-A1 FUSED RING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 삼성에스디아이 주식회사 2015-07-23 WO disclosed
EP-2894157-A1 Condensed cyclic compound and organic light-emitting device including the same Samsung Electronics Co., Ltd (KR) 2015-07-15 EP disclosed
US-20130248849-A1 COMPOSITIONS FOR ELECTRONIC APPLICATIONS E I DUPONT DE NEMOURS AND COMPANY (US) 2013-09-26 US disclosed
US-20130248849-A1 COMPOSITIONS FOR ELECTRONIC APPLICATIONS E I DUPONT DE NEMOURS AND COMPANY (US) 2013-09-26 US disclosed
WO-2012087955-A1 COMPOSITIONS FOR ELECTRONIC APPLICATIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-06-28 WO disclosed
US-20120153272-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-06-21 US disclosed
US-20120153272-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-06-21 US disclosed
US-20090295276-A1 Organic Electroluminescent Device NIPPON STEEL CHEMICAL CO., LTD (JP) 2009-12-03 US disclosed
US-20090295276-A1 Organic Electroluminescent Device NIPPON STEEL CHEMICAL CO., LTD (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030894-B2 Composition for organic optoelectronic device, organic optoelectronic device and display device OR10J3, OCIAD2, OCIAD1 L3MBTL1 4820/4885KDM4E 4422/4885ATM 4252/4885
US-20150228909-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 L3MBTL1 646/4885KDM4E 2145/4885ATM 1406/4885
US-20240032417-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF PIEZO1, TMEM109, SLCO2A1 L3MBTL1 2078/4885KDM4E 3222/4885ATM 3248/4885
US-11844271-B2 Organic compound, composition, organic optoelectronic device, and display apparatus OCIAD1, OXER1, OR10J3 L3MBTL1 4186/4885KDM4E 4321/4885ATM 4140/4885
US-20240023434-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD1, OCIAD2, AOX1 L3MBTL1 4235/4885KDM4E 4085/4885ATM 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.